Efficient synthesis and neuroprotective effect of substituted 1,3-diphenyl-2-propen-1-ones

Journal of Medicinal Chemistry

Volumn 51, Issue 13, 2008, Pages 4054-4058

  Jung, Jae Chul ^a   Jang, Soyong ^a   Lee, Yongnam ^b   Min, Dongguk ^b   Lim, Eunyoung ^b   Jung, Heyin ^b   Oh, Miyeon ^b   Oh, Seikwan ^a   Jung, Mankil ^b  

^a Ewha Womans University School of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3 FLUORO 4 METHOXYPHENYL) 3 (2 HYDROXY 3 METHOXYPHENYL) 2 PROPEN 1 ONE; 1 (3 FLUORO 4 METHOXYPHENYL) 3 (3 HYDROXY 4 METHOXYPHENYL) 2 PROPEN 1 ONE; 1 (3 FLUORO 4 METHOXYPHENYL) 3 (4 HYDROXY 3 METHOXYPHENYL) 2 PROPEN 1 ONE; 1 (BENZO[1,3]DIOXOL 5 YL) 3 (3 HYDROXY 4 METHOXYPHENYL) 2 PROPEN 1 ONE; 1 (BENZO[1,3]DIOXOL 5 YL) 3 (4 HYDROXY 3 METHOXYPHENYL) 2 PROPEN 1 ONE; 1,1 DIPHENYL 2 PICRYLHYDRAZYL; 3 (2 HYDROXY 3 METHOXYPHENYL) 1 (3,4,5 TRIFLUOROPHENYL) 2 PROPEN 1 ONE; 3 (3 HYDROXY 4 METHOXYPHENYL) 1 (3,4,5 TRIFLUOROPHENYL) 2 PROPEN 1 ONE; 3 (4 HYDROXY 3 METHOXYPHENYL) 1 (3,4,5 TRIFLUOROPHENYL) 2 PROPEN 1 ONE; CHALCONE DERIVATIVE; NITRIC OXIDE; RESVERATROL;

ALDOL REACTION; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; MOLECULAR MODEL; NEUROPROTECTION;

ALDEHYDES; ANIMALS; CELL LINE; CELL SURVIVAL; CHALCONE; GLUTARATES; LIPOPOLYSACCHARIDES; MICE; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NEURONS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE CULTURE TECHNIQUES;

EID: 46849086780     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm800221g     Document Type: Article

References (20)

1. Mukherjee, S.; Kumar, V.; Prasad, A. K.; Raj, H. G.; Bracke, M. E.; Olsen, C. E.; Jain, S. C.; Parmar, V. S. Synthetic and biological activity evaluation studies on novel 1,3-diarylpropenones. Bioorg. Med. Chem. 2001, 9, 337-345.
2. Kim, D. Y.; Kim, K. H.; Kim, N. D.; Lee, K. Y.; Han, C. K.; Yoon, J. H.; Moon, S. K.; Lee, S. S.; Seong, B. L. Design and biological evaluation of novel tubulin inhibitors as antimitotic agents using a pharmacophore binding model with tubulin. J. Med. Chem. 2006, 49, 5664-5670.
3. Ono, M.; Hori, M.; Haratake, M.; Tomiyama, T.; Mori, H.; Nakayama, M. Structure-activity relationship of chalcones and related derivatives as ligands for detecting of β-amyloid plaques in the brain. Bioorg. Med. Chem. 2007, 15, 6388-6396.
4. Konieczny, M. T.; Konieczny, W.; Sabisz, M.; Skladanowski, A.; Wakiec, R.; Augustynowicz-Kopec, E.; Zwolska, Z. Synthesis of isomeric, oxathiolone fused chalcones, and comparison of their activity toward various microorganisms and human cancer cells line. Chem. Pharm. Bull. 2007, 55, 817-820.
5. Gschwendt, M.; Kittstein, W.; Furstenberger, G.; Marks, F. The mouse ear edema: a quantitatively evaluable assay for tumor promoting compounds and for inhibitors of tumor promotion. Cancer Lett. 1984, 25, 177-185.
6. Nowakowska, Z. A review of anti-infective and anti-inflammatory chalcones. Eur. J. Med. Chem. 2007, 42, 125-137.
7. Opletalova, V.; Jahodar, L.; Jun, D.; Opletal, L. Chalcones (1,3-diarylpropen-1-ones) and their analogs as potential therapeutic agents for diseases of the cardiovascular system. Ceska Slov. Farm. 2003, 52, 12-19.
8. Afanas'ev, I. B. Signaling functions of free radicals superoxide & nitric oxide under physiological & pathological conditions. Mol. Biotechnol. 2007, 37, 2-4.
9. Esposito, E.; Capasso, M.; di Tomasso, N.; Corona, C.; Pellegrini, F.; Uncini, A.; Vitaglione, P.; Fogliano, V.; Piantelli, M.; Sensi, S. L. Antioxidant strategies based on tomato-enriched food or pyruvate do not affect disease onset and survival in an animal model of amyotrophic lateral sclerosis. Brain Res. 2007, 1168, 90-96.
10. Foresti, R.; Hoque, M.; Monti, D.; Green, C. J.; Motterlini, R. Differential activation of heme oxygenase-1 by chalcones and rosolic acid in endothelial cells. J. Pharmacol. Exp. Ther. 2005, 312, 686-693.
11. Kume, T.; Kawai, Y.; Yoshida, K.; Nakamizo, T.; Kanki, R.; Sawada, H.; Katsuki, H.; Shimohama, S.; Sugimoto, H.; Akaike, A. Protective effect of serofendic acid on glutamate-induced neurotoxicity in rat cultured motor neurons. Neurosci. Lett. 2005, 383, 199-202.
12. Oh, S.; Jang, S.; Kim, D.; Han, I. O.; Jung, J. C. Synthesis and evaluation of biological properties of benzylideneacetophenone derivatives. Arch. Pharm. Res. 2006, 29, 469-475.
13. Arty, I. S.; Timmerman, H.; Samhoedi, M.; Sastrohamidjojo, S.; Van der Goot, H. Synthesis of benzylideneacetophenones and their inhibition of lipid peroxidation. Eur. J. Med. Chem. 2000, 35, 449-457.
14. Lawrence, N. J.; Patterson, R. P.; Ooi, L. L.; Cook, D.; Ducki, S. Effects of α-substitutions on structure and biological activity of anticancer chalcones. Bioorg. Med. Chem. Lett. 2006, 16, 5844 5848.
15. Maiti, A.; Cuendet, M.; Croy, V. L.; Endringer, D. C.; Pezzuto, J. M.; Cushman, M. Synthesis and biological evaluation of (±)-abyssinone II and its analogues as aromatase inhibitors for chemoprevention of breast cancer. J. Med. Chem. 2007, 50, 2799-2806.
16. Bhat, B. A.; Dhar, K. L.; Puri, S. C.; Saxena, A. K.; Shanmugavel, M.; Qazi, G. N. Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents. Bioorg. Med. Chem. Lett. 2005, 15, 3177-3180.
17. Lawinski, M.; Sledzinski, Z.; Kubasik-Juraniec, J.; Spodnik, J. H.; Wozniak, M.; Boguslawski, W. Does resveratrol prevent free radical-induced acute pancreatitis? Pancreas 2005, 31, 43-47.
18. Sivakumar, P. M.; Geetha Babu, S. K.; Mukesh, D. QSAR studies on chalcones and flavonoids as anti-tuberculosis agents using genetic function approximation (GFA) method. Chem. Pharm. Bull. 2007, 55, 44-49.
19. Halgren, T. A. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J. Comput. Chem. 1996, 17, 490-519.
20. Kohn, W.; Becks, A. D.; Parr, R. G. Density functional theory of electronic structure. J. Phys. Chem. 1996, 100, 12974-12980.